Determinants of Mortality among Adult HIV-Infected Patients on Antiretroviral Therapy in a Rural Hospital in Southeastern Nigeria: A 5-Year Cohort Study

Table 3

Hazard ratios of mortality according to predictors for PLWHA in Nigerian Christian Hospital.

Variable	Unadjusted (univariate)		Adjusted (multivariate)
	HR (95% CI)		HR (95% CI)
Sex (female versus male)	0.53 (0.34–0.83)	<0.01
Age group (versus 15–24 years)
25–34 years	1.59 (0.21–12.06)	0.65	1.25 (0.16–9.61)	0.83
35–44 years	2.59 (0.35–18.96)		1.89 (0.26–13.89)	0.53
45+ years	4.9 (0.63–4.06)	0.12	3.60 (0.49–26.56)	0.21
Baseline CD4 staging (versus >500 cells)
350–499	0.65 (0.18–2.36)	0.51	0.66 (0.18–2.40)	0.53
200–349	0.82 (0.23–2.97)	0.33	0.91 (0.25–3.30)	0.88
<200	1.96 (2.03–7.74)	<0.01	3.61 (1.84–7.07)	<0.01
Drug combination
Truvada versus Combivir 1st line	2.36 (1.33–4.19)	<0.01	1.88 (1.05–3.36)	0.03
Truvada versus Combivir 2nd line	1.33 (1.36–0.19)	0.78	1.36 (0.19–9.66)	0.76